Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are Candidates for Systemic Therapy
Public ClinicalTrials.gov record NCT04908475. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 4 Multicenter, Randomized, Open-label, Efficacy Assessor-blinded Study of Risankizumab Compared to Apremilast for the Treatment of Adult Subjects With Moderate Plaque Psoriasis Who Are Candidates for Systemic Therapy
Study identification
- NCT ID
- NCT04908475
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 352 participants
Conditions and interventions
Conditions
Interventions
- Apremilast Drug
- Risankizumab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 8, 2021
- Primary completion
- Apr 19, 2023
- Completion
- Apr 19, 2023
- Last update posted
- Apr 29, 2024
2021 – 2023
United States locations
- U.S. sites
- 26
- U.S. states
- 16
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Total Skin and Beauty Dermatology Center /ID# 233793 | Birmingham | Alabama | 35205 | — |
| Advanced Research Associates - Glendale /ID# 229266 | Glendale | Arizona | 85308 | — |
| Alliance Dermatology and MOHs Center, PC /ID# 229224 | Phoenix | Arizona | 85032 | — |
| UC Davis Health /ID# 229133 | Sacramento | California | 95816-3300 | — |
| Florida Academic Centers Research and Education /ID# 229235 | Coral Gables | Florida | 33134 | — |
| Olympian Clinical Research - Largo /ID# 233792 | Largo | Florida | 33770 | — |
| Renstar Medical Research /ID# 228946 | Ocala | Florida | 34470 | — |
| ForCare Clinical Research /ID# 229135 | Tampa | Florida | 33613-1244 | — |
| Arlington Dermatology /ID# 228945 | Rolling Meadows | Illinois | 60008 | — |
| Dawes Fretzin, LLC /ID# 229010 | Indianapolis | Indiana | 46256 | — |
| Epiphany Dermatology of Kansas LLC /ID# 229221 | Overland Park | Kansas | 66210 | — |
| DermAssociates, LLC /ID# 229016 | Rockville | Maryland | 20850 | — |
| Michigan Center for Research Company /ID# 229136 | Clarkston | Michigan | 48346 | — |
| Henry Ford Medical Center /ID# 229215 | Detroit | Michigan | 48202-3046 | — |
| MediSearch Clinical Trials /ID# 229269 | Saint Joseph | Missouri | 64506 | — |
| Physician Research Collaboration, LLC /ID# 229225 | Lincoln | Nebraska | 68516 | — |
| Advanced Dermatology of the Midlands /ID# 229009 | Omaha | Nebraska | 68144-1105 | — |
| Psoriasis Treatment Center of Central New Jersey /ID# 228943 | East Windsor | New Jersey | 08520 | — |
| University Hospitals Case Medical Center /ID# 229240 | Cleveland | Ohio | 44106 | — |
| Wright State Physicians - Fairborn /ID# 230051 | Fairborn | Ohio | 45324-2640 | — |
| Oregon Dermatology and Research Center /ID# 233462 | Portland | Oregon | 97210 | — |
| Arlington Research Center, Inc /ID# 229264 | Arlington | Texas | 76011 | — |
| Bellaire Dermatology Associates /ID# 230118 | Bellaire | Texas | 77401 | — |
| Center for Clinical Studies - Houston (Binz) /ID# 229263 | Houston | Texas | 77004-8097 | — |
| Center for Clinical Studies - Houston (Binz) /ID# 229272 | Houston | Texas | 77004-8097 | — |
| Premier Clinical Research /ID# 229220 | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 28 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04908475, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 29, 2024 · Synced May 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04908475 live on ClinicalTrials.gov.